Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging Biomarkers in Schizophrenia
NCT03842800Phase 1Completed
- Sponsor
- Yale University
- Start
- Apr 2013
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms), sponsored by Yale University. Primary endpoint: Working Memory (WM) up to 2 hours. Started Apr 2013; status: completed.
Beyond the preview
Go deeper on NCT03842800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03842800.